3
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1–associated central nervous system disease

, , &
Pages 383-386 | Published online: 10 Jul 2009

References

  • Ahmad R, Sindhu S T, Toma E, Morisset R, Ahmad A. 2002. Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis. J Virol. 76: 12448–12456. [PUBMED], [INFOTRIEVE]
  • CDC, 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mort Wkly Rep. 41: 1–19
  • Choi H J, Dinarello C A, Shapiro L. 2001. Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J Infect Dis. 184: 560–568. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • David D, Chevrier D, Treilhou M P, Joussemet M, Dupont B, Theze J, Guesdon J L. 2000. IL-18 underexpression reduces IL-2 levels during HIV infection: a critical step towards the faulty cell-mediated immunity?. AIDS. 14: 2212–2214. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Fassbender K, Mielke O, Bertsch T, Muehlhauser F, Hennerici M, Kurimoto M, Rossol S. 1999. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology. 53: 1104–1106. [PUBMED], [INFOTRIEVE]
  • Jander S, Stoll G. 2001. Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy. J Neuroimmunol. 114: 253–258. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Jander S, Stoll G. 2002. Increased serum levels of the interferon-gamma-inducing cytokine interleukin-18 in myasthenia gravis. Neurology. 59: 287–289. [PUBMED], [INFOTRIEVE]
  • Janssen R S, Cornblath D R, Epstein L G, Foa R P, McArthur J C, Price R W, Asbury A K, Beckett A, Benson D F, Bridge T P, Leventhal C M, Satz P, Saykin A J, Sidtis J J, Tross S. 1991. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 41: 778–785
  • Kawakami K, Qureshi M H, Zhang T, Okamura H, Kurimoto M, Saito A. 1997. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol. 159: 5528–5534. [PUBMED], [INFOTRIEVE]
  • Klein S A, Klebba C, Kauschat D, Pape M, Ozmen L, Hoelzer D, Ottmann O G, Kalina U. 2000. Interleukin-18 stimulates HIV-1 replication in a T-cell line. Eur Cytokine Netw. 11: 47–52. [PUBMED], [INFOTRIEVE]
  • Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol. 70: 281–312. [PUBMED], [INFOTRIEVE]
  • Shapiro L, Puren A J, Barton H A, Novick D, Peskind R L, Shenkar R, Gu Y, Su M S, Dinarello C A. 1998. Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci U S A. 95: 12550–12555. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Torre D, Pugliese A, Speranza F, Martegani R, Tambini R. 2002. Role of interleukin-18 in human immunodeficiency virus type 1 infection. J Infect Dis. 185, 998, author reply. 998–999. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Torre D, Speranza F, Martegani R, Pugliese A, Castelli F, Basilico C, Biondi G. 2000. Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection. AIDS. 14: 2211–2212. [PUBMED], [INFOTRIEVE], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.